The proposed method is found as suitable for routinequantification of lercanidipine in human breast milk.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Abstract: A simple, rapid, precise and accurate isocratic reversed phase HPLC method was developed andvalidated for the determination of lercanidipine hydrochloride in pharmaceutical tablets and spiked human breastmilk.
📊
Key Findings & Data:The chromatographic separation was achieved on C18 (250×4.6 mm×5µm) column using a mobile phaseconsisting of acetonitrile and phospate buffer (pH=4) (55:45, v/v) at a flow rate of 1.1 mL/min and UV detectionat 237 nm.
💡
Conclusion & Impact:The proposed method is found as suitable for routinequantification of lercanidipine in human breast milk.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Abstract: A simple, rapid, precise and accurate isocratic reversed phase HPLC method was developed andvalidated for the determination of lercanidipine hydrochloride in pharmaceutical tablets and spiked human breastmilk. The chromatographic separation was achieved on C18 (250×4.6 mm×5µm) column using a mobile phaseconsisting of acetonitrile and phospate buffer (pH=4) (55:45, v/v) at a flow rate of 1.1 mL/min and UV detectionat 237 nm. The linearity of the proposed method was investigated in the range of 1.0-40 μg/mL (r2=0.9990). Themethod was validated in terms of accuracy, precision, reproducibility, specificity, robustness, and detection andquantification limits, in accordance with ICH guidelines. The proposed method is found as suitable for routinequantification of lercanidipine in human breast milk.
🔖
Cite This Article
GAZİOĞLU, I., TEKKELİ, E. K., ÖNAL, C., TIRIS, G. (2022). High performance liquid chromatographic analysis of lercanidipine in human breast milk. Journal of Chemical Metrology, Cilt: 13 - Sayı: 1, 1–6. https://ajindex.com/articles/560770
K. J. McClellan and B. Jarvis (2000). Lercanidipine - A review of its use in hypertension, Drugs 60, 1123-1140
L. M. Bang, T. M. Chapman and K. L. Goa (2003). Lercanidipine - A review of its efficacy in the management of hypertension, Drugs 63, 2449-2472
M. Burnier, M. Pruijm and G. Wuerzner (2009). Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine? Expert Opin. Drug Metab. Toxicol. 5, 981-987
L. G. Herbette, M. Vecchiarelli, A. Sartani andA. Leonardi (1998). Lercanidipine: short plasma halflife, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties, Blood Press. Suppl. 2, 10-17
V. B. Boralli, E. B. Coelho, S. A. Sampaio, M. P. Marques and V. L. Lanchote (2009). Enantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers, J. Clin. Pharmacol. 49, 205-211
G. Coppi and M. Barchielli (1991). Simple High-Performance Liquid-Chromatographic Method for the Determination of Pgt/1a, a New Immunostimulating Drug, in Biological-Fluids, J. Chromatogr-Biomed. 563, 385-391
I. I. Salem, J. Idrees, J. I. Al Tamimi and P. Farina (2004). Selective and rapid liquid chromatographymass spectrometry method for the determination of lercanidipine in human plasma, J. Chromatogr. B. 803, 201-207
E.M. B. Sabi-mouka, J. E. Agbokponto, E. Zhang, Q. Li and L. Ding (2016). Simultaneous determination of a fixed-dose combination of lercanidipine and valsartan in human plasma by LC–MS-MS: Application to a pharmacokinetic study, J. Chrom. Sci. 54, 1553-1559
A. B. Baranda, C. A. Mueller, R. M. Alonso, R. M. Jimenez and W. Weinmann (2005). Quantitative determination of the calcium channel antagonists amlodipine, lercanidipine, nitrendipine, felodipine, and lacidipine in human plasma using liquid chromatography-tandem mass spectrometry, Ther Drug Monit. 27, 44-52
K. Chen, J. Zhang, S. Liu, D. Zhang, Y. Teng, C. Wei, B. Wang, X. Liu, G. Yuan, R. Zhang, W. Zhao and R. Guo (2012). Simultaneous determination of lercanidipine, benazepril and benazeprilat in plasma by LC-MS/MS and its application to a toxicokinetics study, J. Chromatogr. B, 899, 1-7
X. Li, F. Shi and X. He (2016). A rapid and sensitive LC-MS/MS method for determination of lercanidipine in human plasma and its application in a bioequivalence study in Chinese healthy volunteers, J. Pharm. Biomed. Anal. 12